Eagle Bancorp Announces Earnings Call on October 24, 2024
BETHESDA, Md., Oct. 09, 2024 (GLOBE NEWSWIRE) — Eagle Bancorp, Inc. (the “Company”) (NASDAQ: EGBN), the Bethesda-based holding company for […]
Sotherly Hotels Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call
WILLIAMSBURG, Va., Oct. 09, 2024 (GLOBE NEWSWIRE) — Sotherly Hotels Inc. (NASDAQ: SOHO) (the “Company”) announced that the Company will […]
Global Net Lease Completes $569 Million of Dispositions Through Third Quarter of 2024
NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) — Global Net Lease, Inc. (NYSE: GNL) (“GNL” or the “Company”) today announced […]
XORTX Initiates Precision Medicine Program
CALGARY, Alberta, Oct. 09, 2024 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX […]
UCLOUDLINK GROUP INC. to Present at the LD Micro Main Event XVII Conference
HONG KONG, Oct. 09, 2024 (GLOBE NEWSWIRE) — UCLOUDLINK GROUP INC. (“UCLOUDLINK” or the “Company”) (NASDAQ: UCL), the world’s first […]
VEON Launches KINOM Digital Entertainment Platform in Uzbekistan
Amsterdam and Tashkent, 9 October 2024 – VEON Ltd. (Nasdaq: VEON, Euronext Amsterdam: VEON), a global digital operator, is pleased to […]
InterDigital and Lenovo agree to enter into new license agreement – final terms to be determined in binding arbitration
WILMINGTON, Del., Oct. 09, 2024 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and […]
Cornish Metals Board and Management Update
VANCOUVER, British Columbia, Oct. 09, 2024 (GLOBE NEWSWIRE) — Cornish Metals Inc. (AIM/TSX-V: CUSN) (“Cornish Metals” or the “Company”), a […]
ArcelorMittal announces recommendations from dss+ workplace safety audit
9 October 2024, 08:00 CET ArcelorMittal (the ‘Company’ or the ‘Group’) has today published the recommendations of the comprehensive dss+ […]
Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
SAN DIEGO, Oct. 08, 2024 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the […]
